Laboratory Services for Adeno Associated Virus Based Therapeutics Against SARS-CoV-2

This solicitation seeks quotations for laboratory services to support research on adeno-associated virus based therapeutics against SARS-CoV-2. The National Heart, Lung, and Blood Institute is seeking to establish short term in vitro cell culture systems for detecting AAV transduction and expression, prepare and analyze serum samples from animal models, and perform antibody profiling and histological analysis. Quotations are due by June 22, 2021 and the contractor will perform the services in an AAV biology section laboratory at the National Institutes of Dental and Craniofacial Research in Bethesda, Maryland, with a period of performance from August 2021 to August 2022.

There is no set-aside designated for this procurement. Services will be performed at the National Institutes of Dental and Craniofacial Research in Bethesda, Maryland from August 2021 to August 2022. Preference will be given to offerors having a PhD in a relevant field and five years of postdoctoral research experience including work related to primary cell culture, AAV biology, vaccine development, and gene expression analysis. This procurement falls under NAICS 541715 and PSC R425 with an anticipated budget between $500,000-$1,000,000 to support the period of performance.